Clinical Manifestations of Overactive Bladder With Migraine as a Comorbidity: A Prospective Cross-Sectional Study
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose: The aim of this study was to investigate the clinical manifestations of overactive bladder (OAB) with migraine as a comorbidity and to shed light on possible new treatment strategies.Methods: This study included patients aged 18 years and older who were admitted to urology and neurology outpatient clinics between March 1, 2019 and March 1, 2020 for OAB and migraine. The study questionnaire contained 3 sections: (1) questions on demographic characteristics, (2) a migraine ID test, and (3) the Overactive Bladder Inquiry Form - V8 (OAB-V8) form.Results: A total of 265 patients participated in the study. The average age of the participants was 39.75±11.93 years. The patients were divided into 3 groups according to the coexistence of OAB with migraine: group 1, OAB(+)/migraine(+); group 2, OAB(+)/migraine(-); and group 3, OAB(-)/migraine(+). The mean OAB-V8 score was 22.82 ±8.15 in group 1 and 25.64±7.49 in group 2. The mean OAB-V8 score of OAB patients with migraine as a comorbidity was statistically significantly lower than that of OAB patients without migraine (P=0.015). The median visual analogue scale (VAS) score was 7.11 (range, 2–10) in group 1 and 5.95 (range, 2–10) in group 3. This finding indicates that in patients with migraine, having OAB was associated with significantly higher VAS scores (P<0.001).Conclusions: OAB and migraine may be comorbid conditions coexisting in a single patient. This comorbidity may lead to a lower perception of OAB symptoms in OAB patients or, conversely, to a higher perception of migraine pain. Further studies are needed to elucidate how treatments for each of these diseases can affect the other disease.
Abstract
Purpose: The aim of this study was to investigate the clinical manifestations of overactive bladder (OAB) with migraine as a comorbidity and to shed light on possible new treatment strategies.Methods: This study included patients aged 18 years and older who were admitted to urology and neurology outpatient clinics between March 1, 2019 and March 1, 2020 for OAB and migraine. The study questionnaire contained 3 sections: (1) questions on demographic characteristics, (2) a migraine ID test, and (3) the Overactive Bladder Inquiry Form - V8 (OAB-V8) form.Results: A total of 265 patients participated in the study. The average age of the participants was 39.75±11.93 years. The patients were divided into 3 groups according to the coexistence of OAB with migraine: group 1, OAB(+)/migraine(+); group 2, OAB(+)/migraine(-); and group 3, OAB(-)/migraine(+). The mean OAB-V8 score was 22.82 ±8.15 in group 1 and 25.64±7.49 in group 2. The mean OAB-V8 score of OAB patients with migraine as a comorbidity was statistically significantly lower than that of OAB patients without migraine (P=0.015). The median visual analogue scale (VAS) score was 7.11 (range, 2–10) in group 1 and 5.95 (range, 2–10) in group 3. This finding indicates that in patients with migraine, having OAB was associated with significantly higher VAS scores (P<0.001).Conclusions: OAB and migraine may be comorbid conditions coexisting in a single patient. This comorbidity may lead to a lower perception of OAB symptoms in OAB patients or, conversely, to a higher perception of migraine pain. Further studies are needed to elucidate how treatments for each of these diseases can affect the other disease.
참고문헌 (21)
- Abrams P, "The standardisation of terminology of lower urinary tract function : report from the Standardisation Sub-committee of the International Continence Society", Neurourol Urodyn, 21, pp.167~178 (2002)
- Irwin DE, "Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction", BJU Int, 108, pp.1132~1138 (2011)
- Cheung WW, "Prevalence, evaluation and management of overactive bladder in primary care", BMC Fam Pract, 10, pp.8~ (2009)
- Zumrutbas AE, "Prevalence of lower urinary tract symptoms, overactive bladder and urinary incontinence in western Turkey: results of a population-based survey", Int J Urol, 21, pp.1027~1033 (2014)
- Chung JH, "The association between overactive bladder and fibromyalgia syndrome : a community survey", Neurourol Urody, 32, pp.66~69 (2013)
- 손연정, "Overactive Bladder is a Distress Symptom in Heart Failure", International Neurourology Journal, 22(2), pp.77~82 (2018), 대한배뇨장애요실금학회
- Coyne KS, "Rsik factors and comorbid conditions associated with lower urinary tract symptoms : EpiLUTS", BJU Int, 103(Suppl 3), pp.24~ (2009)
- Coyne KS, "The prevalence of chronic constipations and faecal incontinence among men and women with symptoms of overactive bladder", BJU Int, 107, pp.254~261 (2001)
- Lai HH, "Systemic non-urologic symptoms in patients with overactive bladder", J Urol, 196, pp.467~472 (2016)
- Ramos ML, "Comorbidity between idiopathic overactive bladder and chronic migraine", Cephalalgia, 38, pp.581~584 (2018)
- Headache Classification Committee of the International Headache Society (IHS), "The International Classification of Headache Disorders", Cephalalgia, 38, pp.1~211 (2018)
- Acquadro C, "Translating overactive bladder questionnaires in 14 languages", Urology, 67, pp.536~540 (2006)
- Tarcan T, "AOB-V8 aşırı aktif mesane sorgulama formu validasyon çalışması", Üroloji Bülteni, 21, pp.113~116 (2012)
- Breslau N, "The impact of migraine. Epidemiology, risk factors and co-morbidities", Neurology, 56, pp.4~12 (2001)
- Zarifoglu M, "The Turkish headache epidemiology study group. An epidemiological study of headache in Turkey: a nationwide survey", Neurology, 50(Suppl 4), pp.80~85 (1998)
- Pavlovic JM, "Sex-related influences in migraine", J Neurosci Res, 95, pp.587~593 (2017)
- Gazerani P, "Sex-specific pharmacotherapy for migraine : a narrative review", Front Neurosci, 14, pp.222~ (2020)
- Altman D, "Somatic comorbidity in women with overactive bladder syndrome", J Urol, 196, pp.473~477 (2016)
- Fowler CJ, "The neural control of micturition", Nat Rev Neurosci, 9, pp.453~466 (2008)
- Rapp DE, "Botulinum toxin type a inhibits calcitonin gene-related peptide from isolated rat bladder", J Urol, 175, pp.1138~1142 (2006)
- Cernuda-Morollon E, "OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine", Pain, 156, pp.820~824 (2015)